vs
美泰（MAT）与Privia Health Group, Inc.（PRVA）财务数据对比。点击上方公司名可切换其他公司
美泰的季度营收约是Privia Health Group, Inc.的1.6倍（$862.2M vs $541.2M），美泰净利率更高（7.1% vs 1.7%，领先5.4%），Privia Health Group, Inc.同比增速更快（17.4% vs 4.3%），过去两年Privia Health Group, Inc.的营收复合增速更高（14.2% vs -10.6%）
美泰是美国知名玩具及娱乐企业，旗下影视制作部门美泰影业运营时间为2018年9月6日至2025年6月2日。其前身为2013年10月16日成立的美泰Playground Productions，更早可追溯至美泰娱乐、美泰工作室等集团原有娱乐业务品牌。
Privia Health Group, Inc.是总部位于美国的医疗科技与服务企业，为独立诊所、医疗系统和医疗支付方提供价值导向型医疗解决方案，涵盖人群健康管理、患者互动平台、护理协调支持及行政流程优化工具，助力提升诊疗效果、降低医疗参与方运营成本。
MAT vs PRVA — 直观对比
营收规模更大
MAT
是对方的1.6倍
$541.2M
营收增速更快
PRVA
高出13.1%
4.3%
净利率更高
MAT
高出5.4%
1.7%
两年增速更快
PRVA
近两年复合增速
-10.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $862.2M | $541.2M |
| 净利润 | $61.0M | $9.2M |
| 毛利率 | 44.9% | — |
| 营业利润率 | — | 2.1% |
| 净利率 | 7.1% | 1.7% |
| 营收同比 | 4.3% | 17.4% |
| 净利润同比 | 251.4% | 108.0% |
| 每股收益（稀释后） | $0.20 | $0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MATPRVA
| Q1 26 | $862.2M | — | ||
| Q4 25 | $1.8B | $541.2M | ||
| Q3 25 | $1.7B | $580.4M | ||
| Q2 25 | $1.0B | $521.2M | ||
| Q1 25 | $826.6M | $480.1M | ||
| Q4 24 | $1.6B | $460.9M | ||
| Q3 24 | $1.8B | $437.9M | ||
| Q2 24 | $1.1B | $422.3M |
净利润MATPRVA
| Q1 26 | $61.0M | — | ||
| Q4 25 | $106.2M | $9.2M | ||
| Q3 25 | $278.4M | $6.9M | ||
| Q2 25 | $53.4M | $2.7M | ||
| Q1 25 | $-40.3M | $4.2M | ||
| Q4 24 | $140.9M | $4.4M | ||
| Q3 24 | $372.4M | $3.5M | ||
| Q2 24 | $56.9M | $3.5M |
毛利率MATPRVA
| Q1 26 | 44.9% | — | ||
| Q4 25 | 45.9% | — | ||
| Q3 25 | 50.0% | — | ||
| Q2 25 | 50.9% | — | ||
| Q1 25 | 49.4% | — | ||
| Q4 24 | 50.7% | — | ||
| Q3 24 | 53.1% | — | ||
| Q2 24 | 49.2% | — |
营业利润率MATPRVA
| Q1 26 | — | — | ||
| Q4 25 | 8.0% | 2.1% | ||
| Q3 25 | 21.9% | 2.5% | ||
| Q2 25 | 7.7% | 0.6% | ||
| Q1 25 | -6.4% | 1.1% | ||
| Q4 24 | 9.6% | 1.1% | ||
| Q3 24 | 26.5% | 1.3% | ||
| Q2 24 | 7.7% | 1.2% |
净利率MATPRVA
| Q1 26 | 7.1% | — | ||
| Q4 25 | 6.0% | 1.7% | ||
| Q3 25 | 16.0% | 1.2% | ||
| Q2 25 | 5.2% | 0.5% | ||
| Q1 25 | -4.9% | 0.9% | ||
| Q4 24 | 8.6% | 1.0% | ||
| Q3 24 | 20.2% | 0.8% | ||
| Q2 24 | 5.3% | 0.8% |
每股收益（稀释后）MATPRVA
| Q1 26 | $0.20 | — | ||
| Q4 25 | $0.32 | $0.08 | ||
| Q3 25 | $0.88 | $0.05 | ||
| Q2 25 | $0.16 | $0.02 | ||
| Q1 25 | $-0.12 | $0.03 | ||
| Q4 24 | $0.40 | $0.03 | ||
| Q3 24 | $1.09 | $0.03 | ||
| Q2 24 | $0.17 | $0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $866.0M | $479.7M |
| 总债务越低越好 | $2.3B | — |
| 股东权益账面价值 | $2.1B | $737.2M |
| 总资产 | $6.3B | $1.4B |
| 负债/权益比越低杠杆越低 | 1.11× | — |
8季度趋势，按日历期对齐
现金及短期投资MATPRVA
| Q1 26 | $866.0M | — | ||
| Q4 25 | $1.2B | $479.7M | ||
| Q3 25 | $691.9M | $441.4M | ||
| Q2 25 | $870.5M | $390.1M | ||
| Q1 25 | $1.2B | $469.3M | ||
| Q4 24 | $1.4B | $491.1M | ||
| Q3 24 | $723.5M | $422.0M | ||
| Q2 24 | $722.4M | $387.4M |
总债务MATPRVA
| Q1 26 | $2.3B | — | ||
| Q4 25 | $2.3B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.3B | — | ||
| Q4 24 | $2.3B | — | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.3B | — |
股东权益MATPRVA
| Q1 26 | $2.1B | — | ||
| Q4 25 | $2.2B | $737.2M | ||
| Q3 25 | $2.3B | $709.1M | ||
| Q2 25 | $2.2B | $682.9M | ||
| Q1 25 | $2.1B | $659.4M | ||
| Q4 24 | $2.3B | $635.2M | ||
| Q3 24 | $2.3B | $614.9M | ||
| Q2 24 | $2.0B | $595.4M |
总资产MATPRVA
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.6B | $1.4B | ||
| Q3 25 | $6.6B | $1.4B | ||
| Q2 25 | $6.2B | $1.3B | ||
| Q1 25 | $6.2B | $1.2B | ||
| Q4 24 | $6.5B | $1.1B | ||
| Q3 24 | $6.5B | $1.1B | ||
| Q2 24 | $5.9B | $1.1B |
负债/权益比MATPRVA
| Q1 26 | 1.11× | — | ||
| Q4 25 | 1.04× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 1.08× | — | ||
| Q1 25 | 1.10× | — | ||
| Q4 24 | 1.03× | — | ||
| Q3 24 | 1.01× | — | ||
| Q2 24 | 1.18× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $127.5M |
| 自由现金流经营现金流 - 资本支出 | $-88.1M | — |
| 自由现金流率自由现金流/营收 | -10.2% | — |
| 资本支出强度资本支出/营收 | 7.6% | — |
| 现金转化率经营现金流/净利润 | — | 13.93× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流MATPRVA
| Q1 26 | — | — | ||
| Q4 25 | $796.6M | $127.5M | ||
| Q3 25 | $72.0M | $52.0M | ||
| Q2 25 | $-300.1M | $8.0M | ||
| Q1 25 | $24.8M | $-24.1M | ||
| Q4 24 | $862.1M | $74.8M | ||
| Q3 24 | $155.8M | $33.2M | ||
| Q2 24 | $-252.9M | $34.5M |
自由现金流MATPRVA
| Q1 26 | $-88.1M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
自由现金流率MATPRVA
| Q1 26 | -10.2% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
资本支出强度MATPRVA
| Q1 26 | 7.6% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金转化率MATPRVA
| Q1 26 | — | — | ||
| Q4 25 | 7.50× | 13.93× | ||
| Q3 25 | 0.26× | 7.58× | ||
| Q2 25 | -5.62× | 2.97× | ||
| Q1 25 | — | -5.70× | ||
| Q4 24 | 6.12× | 17.00× | ||
| Q3 24 | 0.42× | 9.38× | ||
| Q2 24 | -4.45× | 9.94× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MAT
暂无分部数据
PRVA
| FFS Patient Care | $364.4M | 67% |
| Capitated Revenue | $71.4M | 13% |
| Shared Savings | $46.9M | 9% |
| FFS Administrative Services | $36.0M | 7% |
| Care Management Fee PMPM | $20.0M | 4% |
| Other Revenue | $2.5M | 0% |
